Cytogenetics of melanoma: a review.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Journal of the Association of Genetic Technologists

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 26030295
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Enhanced Detection of Spitzoid Melanomas Using Fluorescence In Situ Hybridization With 9p21 as an Adjunctive Probe

  2012cited by this paper
• Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis.

  2012cited by this paper
• The role of CCND1 alterations during the progression of cutaneous malignant melanoma

  2012cited by this paper
• Fluorescence in situ hybridization for distinguishing cellular blue nevi from blue nevus‐like melanoma

  2011cited by this paper
• Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi

  2011influential reference
• Update on fluorescence in situ hybridization in melanoma: state of the art.

  2011cited by this paper
• Use of Fluorescence In situ Hybridization (FISH) to Distinguish Intranodal Nevus From Metastatic Melanoma

  2010cited by this paper
• Melanoma from bench to bedside: meeting report from the 6th international melanoma congress

  2010cited by this paper
• Correlating array comparative genomic hybridization findings with histology and outcome in spitzoid melanocytic neoplasms.

  2010influential reference
• Classifying ambiguous melanocytic lesions with FISH and correlation with clinical long-term follow up

  2010influential reference
• Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using RREB1, MYB, Cep6, and 11q13 probes in melanoma subtypes.

  2010cited by this paper
• Fluorescence In Situ Hybridization (FISH) as an Ancillary Diagnostic Tool in the Diagnosis of Melanoma

  2009cited by this paper
• Translating uveal melanoma cytogenetics into clinical care.

  2009cited by this paper
• Distinguishing Epithelioid Blue Nevus From Blue Nevus-like Cutaneous Melanoma Metastasis Using Fluorescence In Situ Hybridization

  2009cited by this paper
• A fluorescence in situ hybridization (FISH) procedure to assist in differentiating benign from malignant melanocytic lesions.

  2009cited by this paper
• Comparative genomic hybridization for the diagnosis of melanoma

  2009cited by this paper
• Fluorescence in Situ Hybridization for Distinguishing Nevoid Melanomas From Mitotically Active Nevi

  2009cited by this paper
• Diagnosis of cutaneous melanocytic tumours by four‐colour fluorescence in situ hybridisation

  2009cited by this paper
• Frequent somatic mutations of GNAQ in uveal melanoma and blue nevi

  2008cited by this paper
• Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.

  2008cited by this paper
• The RAS/mitogen activated protein (MAP) kinase pathway in melanoma biology and therapeutics

  2007cited by this paper
• Somatic activation of KIT in distinct subtypes of melanoma.

  2006cited by this paper
• Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma.

  2006cited by this paper
• Structure and regulation of Kit protein-tyrosine kinase--the stem cell factor receptor.

  2005cited by this paper
• Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors.

  2005cited by this paper
• Distinct sets of genetic alterations in melanoma.

  2005cited by this paper
• Genetic interaction between NRAS and BRAF mutations and PTEN/MMAC1 inactivation in melanoma.

  2004cited by this paper
• Classifying melanocytic tumors based on DNA copy number changes.

  2003cited by this paper
• Mutations of the BRAF gene in human cancer

  2002cited by this paper
• Cyclin D1 is a candidate oncogene in cutaneous melanoma.

  2002cited by this paper
• Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization.

  2001cited by this paper
• Relative reciprocity of NRAS and PTEN/MMAC1 alterations in cutaneous melanoma cell lines.

  2000cited by this paper
• Early detection and treatment of skin cancer.

  2000cited by this paper
• Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma.

  1999cited by this paper
• Increasing Complexity of the Ras Signaling Pathway*

  1998cited by this paper
• Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation.

  1998cited by this paper
• Increased chromosome 20 copy number detected by fluorescence in situ hybridization (FISH) in malignant melanoma

  1997cited by this paper
• Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis

  1997cited by this paper
• A genetic model of melanoma tumorigenesis based on allelic losses

  1995cited by this paper
• Cytogenetics of 158 patients with regional or disseminated melanoma. Subset analysis of near-diploid and simple karyotypes.

  1995cited by this paper
• Comparative genomic hybridization: an overview.

  1994cited by this paper
• Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization.

  1994cited by this paper
• Fluorescence in situ hybridization.

  1993cited by this paper
• A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4

  1993cited by this paper
• Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.

  1989cited by this paper

• Genomics and Epigenomics in the Molecular Biology of Melanoma—A Prerequisite for Biomarkers Studies

  2022cites this paper
• Genetics of metastasis: melanoma and other cancers

  2018cites this paper